Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-3-10
|
pubmed:abstractText |
To determine the potential of ovine interleukin 1 (IL-1) as a vaccine adjuvant in sheep, we have expressed and purified recombinant ovine IL-1 beta (rovIL-1 beta) from bacterial cultures using a modified form of the ovine IL-1 beta cDNA. Adjuvant trials using the model protein avidin demonstrated that rovIL-1 beta when administered in association with a compound providing a slow-release mechanism, resulted in significant enhancement of specific serum antibody levels in both mice and sheep. In a dose-response experiment in sheep, intradermal immunization with avidin plus either 10 or 100 micrograms of rovIL-1 beta in aluminium hydroxide resulted in antibody levels four- to eightfold higher than immunizations without rovIL-1 beta. The addition of rovIL-1 beta also resulted in a more severe DTH response to avidin indicating that rovIL-1 beta is able to enhance both humoral and cell-mediated responses to avidin. The highest antibody titres were observed when sheep received rovIL-1 beta in both the primary and secondary immunizations although the addition of rovIL-1 beta in only one of the immunizations still resulted in a significant increase in antibody levels. Additional experiments showed that rovIL-1 beta and avidin must be administered in a site drained by the same lymph node for the adjuvant effect of rovIL-1 beta to be observed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8303935-Adjuvants, Immunologic,
pubmed-meshheading:8303935-Amino Acid Sequence,
pubmed-meshheading:8303935-Animals,
pubmed-meshheading:8303935-Antibody Formation,
pubmed-meshheading:8303935-Avidin,
pubmed-meshheading:8303935-Base Sequence,
pubmed-meshheading:8303935-Cells, Cultured,
pubmed-meshheading:8303935-Female,
pubmed-meshheading:8303935-Hypersensitivity, Delayed,
pubmed-meshheading:8303935-Interleukin-1,
pubmed-meshheading:8303935-Lymphocyte Activation,
pubmed-meshheading:8303935-Male,
pubmed-meshheading:8303935-Mice,
pubmed-meshheading:8303935-Mice, Inbred BALB C,
pubmed-meshheading:8303935-Molecular Sequence Data,
pubmed-meshheading:8303935-Recombinant Proteins,
pubmed-meshheading:8303935-Sheep
|
pubmed:year |
1994
|
pubmed:articleTitle |
Production and in vivo use of recombinant ovine IL-1 beta as an immunological adjuvant.
|
pubmed:affiliation |
Centre for Animal Biotechnology, School of Veterinary Science, University of Melbourne, Parkville, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|